GlobalData on MSN
Abbott reports positive VERITAS study results for AFib
VERITAS involved 400 patients at 34 sites across Europe, Canada, and the US.
24/7 Wall St. on MSN
Abbott Labs just extended its dividend aristocrat status: What comes next?
Quick Read Abbott Laboratories (ABT) raised its quarterly dividend to $0.63 with a 60.4% free cash flow payout ratio.
The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus ...
Feb 4 (Reuters) - Medical device maker Abbott Laboratories has reported 860 serious injuries linked to the recall of some of ...
Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.
Medical Device Network on MSN
Abbott touts neuromodulation portfolio’s long-term benefits
Abbott’s five-year data highlighted neuromodulation therapies’ role in reducing healthcare and patient burdens associated with chronic pain.
Republican Gov. Greg Abbott threatened to arrest and expel the Texas House Democrats who fled the state to avoid a redistricting vote if they do not return by Monday afternoon. Dozens of Texas' ...
Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...
ABBOTT PARK, Ill., Jan. 22, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results